High Future Coronary Event Risk in Chronic Kidney Disease

This article originally appeared here.
Share this content:
High Future Coronary Event Risk in Chronic Kidney Disease
High Future Coronary Event Risk in Chronic Kidney Disease

(HealthDay News) – Patients with chronic kidney disease (CKD) have higher rates of myocardial infarction (MI) than those with diabetes, according to a study published online June 19 in The Lancet.

Marcello Tonelli, MD, of the University of Alberta in Edmonton, Canada, and colleagues examined whether CKD should be considered as a coronary heart disease risk equivalent using a population-based cohort with measures of estimated glomerular filtration rate (eGFR) and proteinuria. The unadjusted rates and relative rates of MI during follow-up were calculated for five risk groups: individuals with previous MI (with or without diabetes or CKD) and four mutually exclusive groups of those without previous MI classified by the presence or absence of CKD and diabetes.

During a median follow-up of 48 months, the researchers found that 11,340 of 1,268,029 participants were admitted with MI. Individuals with previous MI had the highest unadjusted rate of MI (18.5 per 1,000 person-years). Among individuals without previous MI, the MI rate was lower for those with diabetes, without CKD, than for individuals with CKD, without diabetes (5.4 vs. 6.9 per 1,000 person-years). Compared to those with CKD, defined by eGFR of less than 45mL/min/1.73m² and severely increased proteinuria, the rate of incident MI was considerably lower for those with diabetes (6.6 vs. 12.4 per 1,000 person-years).

"Our findings suggest that chronic kidney disease could be added to the list of criteria defining people at highest risk of future coronary events," the authors write.

Two authors disclosed financial ties to the pharmaceutical industry.

Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

Related Resources

You must be a registered member of Cancer Therapy Advisor to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings


Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs